Enfermedades Sistémicas de Base Autoinmune

Rubio, E; Moreno, MJ; Gallego, A; Castrejón, I; Cobo, A; Moyano, S; Comellas, M.

Use of Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis in Spain and Barriers to Implementation: A Delphi Study

ADVANCES IN THERAPY. 2025; : [doi:10.1007/s12325-025-03300-w]

Rua-Figueroa, I; Pérez-Veiga, N; Rodríguez-Almaraz, E; Galindo-Izquierdo, M; Erausquin, C; Fernandez-Nebro, A; Itzazelaia, EU; Serrano-Benavente, B; Alén, JC; Manrique-Arija, S; Senabre, JM; Bernal, JA; Narvaez, J; Tomero, E; Aurrecoechea, E; Ibáñez-Barceló, M; Segarra, VT; Sangüesa, C; Freire-González, M; García-Villanueva, MJ; Taboada, VM; Arevalo, M; Morales, CM; Iñiguez, C; Perez, A; Salgado, E; Carrión-Barberà, I; Andreu, JL; Cobo, T; Horcada, L; Bonilla, G; Lozano-Rivas, N; Exposito, L; Montilla, C; Toyos, FJ; Ibarguengoitia-Barrena, O; Pascual, EV; Medina, JN; Menor-Almagro, R; Ivorra, JAR; Jiménez, AM; Nolla, JM; Pego-Reigosa, JM.

Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort

LUPUS SCIENCE & MEDICINE. 2025; 12(2): [doi:10.1136/lupus-2025-001633]

Georgiadis, S; Di Giuseppe, D; Scherer, A; Hetland, ML; Jones, GT; Glintborg, B; Loft, AG; Wallman, JK; Michelsen, B; Kristianslund, EK; Yazici, A; Birlik, M; Zavada, J; Nissen, MJ; Ciurea, A; Gudbjornsson, B; Palsson, O; Rotar, Z; Tomsic, M; Relas, H; Huhtakangas, J; Rodrigues, AM; Santos, MJ; Castrejon, I; Diaz-González, F; van de Sande, M; Hellamand, P; Ornbjerg, LM.

Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study

Bmc Rheumatology. 2025; 9(1): [doi:10.1186/s41927-025-00527-6]

Ravelli, A; Rosina, S; Macmahon, JM; Baird, T; Rebollo-Gime, AI; Hinze, C; Mccann, LJ; Reed, AM; Rider, LG; Arvigo, M; Bader-Meunier, B; Bruno, C; Caifeng, L; Campanilho-Marques, R; Cuccato, S; Fiorillo, C; Hahn, NA; Huber, AM; Jansen, M; Kasapcopur, O; Katsikas, MM; Kim, S; Livermore, P; Maillard, S; Malattia, C; Migowa, AN; Miyamae, T; Murphy, R; Nicolai, R; Papadopoulou, C; Pilkington, C; Sanner, H; Sawhney, S; Smolewska, E; Tarvin, SE; Tiller, G; Toplak, N; Wedderburn, LR; Bovis, F; Consolaro, A; Feldman, BM.

Treating juvenile dermatomyositis to target: Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-endorsed recommendations from an international task force

ANNALS OF THE RHEUMATIC DISEASES. 2025; 84(7): 1055-1067 [doi:10.1016/j.ard.2025.04.024]

Fernández-Castro, M; Plaza-Almuedo, Z; Rosas, J; Martínez-Taboada, V; Olivé, A; Menor-Almagro, R; Serrano-Benavente, B; Font-Urgelles, J; García-Aparicio, A; Manrique-Arija, S; García-Vadillo, JA; López-González, R; Narváez, J; Rodriguez-Lozano, B; Galisteo, C; González-Martín, J; Vela-Casasempere, P; Bohórquez, C; Erausquin, C; Paredes-Romero, B; Riancho-Zarrabeitia, L; Melchor-Diaz, S; Pego-Reigosa, JM; Heredia, S; Moriano, C; Blazquez-Cañamero, MA; Estrada, P; Júdez, E; Belzunegui, JM; Ramos, C; Sánchez-Alonso, F; Andreu, JL; Systemic Autoimmune Dis Grp Spanish Soc Rheumatology EAS-SER.

Long-term changes in Sjogren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry

RHEUMATOLOGY INTERNATIONAL. 2025; 45(7): [doi:10.1007/s00296-025-05909-0]

Rebollo-Giménez, AI; Ridella, F; Orsi, SM; Aldera, E; Burrone, M; Natoli, V; Rosina, S; Consolaro, A; Naredo, E; Ravelli, A; Cangelosi, D.

Forecasting Achievement of Inactive Disease in Juvenile Idiopathic Arthritis with Artificial Intelligence

Children-Basel. 2025; 12(6): [doi:10.3390/children12060741]

Caponcello, MG; Navarro, PO; Bonazzetti, C; Campoli, C; Savoldi, A; Gentilotti, E; Monforte, AD; Lo Caputo, S; Otero-Varela, L; Castrejón, I; Tacconelli, E; Rodríguez-Baño, J; Palacios-Baena, ZR.

ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases

CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(8): 37-43 Nº de citas: 1 [doi:10.1016/j.cmi.2025.02.030]

Pons, M; Georgiadis, S; Hetland, ML; Ahmadzay, ZF; Rasmussen, S; Christiansen, SN; Di Giuseppe, D; Wallman, JK; Pavelka, K; Závada, J; Codreanu, C; Glintborg, B; Loft, AG; Santos, H; Lourenço, MH; Nissen, MJ; Ciurea, A; Kuusalo, L; Rantalaiho, V; Michelsen, B; Mielnik, P; Pirkmajer, KP; Rotar, Z; Gudbjornsson, B; Palsson, O; van der Horst-bruinsma, I; van de Sande, M; Castrejón, I; Macfarlane, GJ; Laas, K; Ostergaard, M; Ornbjerg, LM.

Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network

JOURNAL OF RHEUMATOLOGY. 2025; 52(6): 572-582 Nº de citas: 1 [doi:10.3899/jrheum.2024-0920]

Michelsen, B; Ostergaard, M; Nissen, MJ; Ciurea, A; Möller, B; Ornbjerg, LM; Horák, P; Glintborg, B; Macdonald, A; Laas, K; Sokka-Isler, T; Gudbjornsson, B; Iannone, F; Hellamand, P; Kvien, TK; Rodrigues, AM; Codreanu, C; Rotar, Z; Castrejón, I; Wallman, JK; Pavelka, K; Loft, AG; Heddle, M; Vorobjov, S; Relas, H; Gröndal, G; Gremese, E; van der Horst-bruinsma, I; Kristianslund, EK; Santos, MJ; Mogosan, C; Tomsic, M; Diaz-Gonzalez, F; Di Giuseppe, D; Nielsen, SW; Hetland, ML.

Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

HEALTH POLICY. 2025; 156: [doi:10.1016/j.healthpol.2025.105311]

Almaraz, ER; Salman-Monte, TC; Calvo-Alen, J; Ajo, MJB; Alvaro, JMAG; Bernabeu, P; Blasco, JB; Ortega, SP; Renau, RR; Marsinach, CS; Galvez-Fernandez, M; Bahamontes-Rosa, N; Hernández, JSC; Izquierdo, MG.

Doctor-patient communication in Systemic Lupus Erythematosus: Insights from the LupusVoice study

Ssm-Qualitative Research In Health. 2025; 7: Nº de citas: 1 [doi:10.1016/j.ssmqr.2025.100528]

Boteanu, A; Bethencourt, JJ; Calzada-Hernández, J; Clemente, D; Nieto-González, JC; López, C; Luque, L; Calvo, I.

Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain

Pediatric Rheumatology. 2025; 23(1): [doi:10.1186/s12969-025-01113-3]

Galíndez-Agirregoikoa, E; Prieto-Peña, D; García-Vivar, ML; Otano, JMB; Joven-Ibáñez, B; Vergara-Dangond, C; Pavía-Pascual, M; Urionaguena-Onaindia, I; Alvarez, LV; Larrubia, MAP; Giráldez, CR; Garcia-Vicuña, R; Jovani, V; Martínez-Ferrer, A; Martínez-Losa, MM; Hernández, TG; González, RA; Urruticoechea-Arana, A; Macía-Villa, C; Gorostiza, I; Alonso, RB.

Treatment with Upadacitinib in Difficult-to-Treat (D2T) Psoriatic Arthritis (PsA): A National Multicenter Study of the First 134 Patients in Clinical Practice

Sci. 2025; 7(2): [doi:10.3390/sci7020067]

Vela-Casasempere, P; Otero-Varela, L; Sabater, SG; Alameda, RC; Fernández, CC; Calvo-Gutiérrez, J; Pérez-Vera, Y; Arija, SM; Bustabad, S; Ruiz, JM; Montesino, MDR; Gutiérrez, LR; Varela, AM; Ramos, MJM; Sánchez-Alonso, F; Castrejón, I.

Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry

ARTHRITIS RESEARCH & THERAPY. 2025; 27(1): [doi:10.1186/s13075-025-03571-2]

López-Medina C; Otero-Varela L; Sánchez-Alonso F; Jovaní V; Expósito-Pérez L; Melchor-Díaz S; Pérez-Vera Y; Pretel-Ruiz P; Manero J; Mera-Varela A; Mateo L; Ruiz-Montesino D; Lorenzo-Martín JA; Pedraz-Penalva T; Castrejón I.

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry.

Reumatologia Clinica. 2025; 21(5): 501872-501872 [doi:10.1016/j.reumae.2025.501872]

López-Medina, C; Otero-Varela, L; Sánchez-Alonso, F; Jovaní, V; Expósito-Pérez, L; Melchor-Díaz, S; Pérez-Vera, Y; Pretel-Ruiz, P; Manero, J; Mera-Varela, A; Mateo, L; Ruiz-Montesino, D; Lorenzo-Martín, JA; Pedraz-Penalva, T; Castrejón, I.

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry

Reumatologia Clinica. 2025; 21(5): [doi:10.1016/j.reuma.2025.501872]

Pons, M; Georgiadis, S; Ostergaard, M; Ahmadzay, ZF; Glintborg, B; Heberg, J; Christensen, SN; Rasmussen, S; Loft, AG; Castrejón, I; Sánchez-Alonso, F; Iannone, F; Nordström, D; Hokkanen, AM; Ciurea, A; Nissen, MJ; Závada, J; Pavelka, K; Rotar, Z; Pirkmajer, KP; Michelsen, B; Mielnik, P; Bernardes, M; Khmelinskii, N; Laas, K; Vorobjov, S; Codreanu, C; Macfarlane, GJ; Jones, GT; Gudbjornsson, B; Palsson, O; Wallman, JK; van der Horst-bruinsma, I; Onen, F; Hetland, ML; Ornbjerg, LM.

Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis

JOINT BONE SPINE. 2025; 92(3): Nº de citas: 1 [doi:10.1016/j.jbspin.2024.105824]

Clemente, D; Leon, L; Nieto-Gonzalez, JC; Boteanu, AL; Folguera, LT; García-Fernández, AA; Muñoz, HA; Palomeque, A; Robledillo, JCL; Abasolo, L.

Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis

Pediatric Rheumatology. 2025; 23(1): Nº de citas: 1 [doi:10.1186/s12969-025-01097-0]

Chamorro-de-Vega, E; González, CM; Menchén, L; Baniandrés, O; Herranz, A; Lobo-Rodríguez, C; Romero-Jiménez, R; Ais-Larisgoitia, A; Lobato-Matilla, E; López-Esteban, A; López-Calleja, A; Marín-Jiménez, I; Monteagudo, I; de los Rios, PM; Nieto, JC; Ferris-Villanueva, M; Lizcano, MJ; Moreno, MPS; Sanjurjo, M; De Sanjose, SG.

New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases

INTERNATIONAL JOURNAL OF INTEGRATED CARE. 2025; 25(2): [doi:10.5334/ijic.7741]